Safety of Russian-Backbone Trivalent, Live Attenuated Seasonal Influenza Vaccine in Healthy Subjects: Open-Label, Non-randomized Phase 4 Study.

Introduction And Aim: A trivalent live attenuated influenza vaccine (Nasovac-S) was developed and licensed in India. A phase 4 study was conducted to assess safety.

Methodology: This non-randomized, open-label, single-arm study among individuals ≥ 2 years of age involved administration of 0.

Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.

Measles, Mumps, and Rubella (MMR) are vaccine preventable viral infections, which cause significant mortality and morbidity globally. Increased incidence rates of these infectious diseases are observed in young adults. Information on seroprevalence data on MMR in India is limited.